About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Houston | 107 Studies

Clinical Trials Multiple SclerosisHouston

Multiple Sclerosis Clinical Trials in Houston

Find 107 clinical trials for multiple sclerosis near Houston, Texas. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 107 trials

TerminatedMS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus CopaxoneThe purpose of this study was to demonstrate that at least one dose (0.5 mg followed by 0.25 mg) of fingolimod is superior to glatiramer acetate 20 mg SC in reducing the ARR up to…NCT01633112·Cullman, Alabama and 129 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedHigh Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple SclerosisMultiple Sclerosis is a disease that may be caused by the immune system reacting against the nervous system.NCT00040482·Houston, Texas

TerminatedNeurogenic Dysphonia/Dysphagia RegistryThe Neurogenic Dysphonia/Dysphagia Registry is designed to be purely observational (i.e. non-interventional, exploratory).NCT02493491·La Jolla, California and 11 others

CompletedA Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple SclerosisThis study will evaluate the pharmacokinetics, safety and tolerability, and immunogenicity of ocrelizumab administered subcutaneously to participants with multiple sclerosis (MS).NCT03972306·Aurora, Colorado and 17 others

WithdrawnA Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple SclerosisThe main purpose of this study is to assess efficacy and safety of pirtobrutinib in participants with relapsing multiple sclerosis.NCT06104683·Tampa, Florida and 3 others

Active not recruitingEfficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisThe purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral dose of teriflunomide in male…NCT06141473·Birmingham, Alabama and 381 others

CompletedExamining a Wheelchair Exercise-training Intervention for Persons With Multiple SclerosisThe goal of this randomized controlled clinical trial is to examine the feasibility and initial efficacy of undertaking and delivering a novel, stakeholder-informed exercise…NCT05888727·Houston, Texas

RecruitingBest Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hematopoietic Stem Cell…NCT04047628·Palo Alto, California and 22 others

TerminatedStudy of Evobrutinib in Participants With RMS (evolutionRMS 1)The study is to evaluate the efficacy and safety of evobrutinib administered orally twice daily versus Teriflunomide (Aubagio®), administered orally once daily in participants…NCT04338022·Mobile, Alabama and 278 others

CompletedA Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple SclerosisStudy Title: A Serologic Study to Correlate b-IFN NAb titers to b-IFN Induced Biomarker Response in Patients with Multiple Sclerosis Objectives: Subjects currently on any of the…NCT00288990·Birmingham, Alabama and 27 others

RecruitingNeuromodulating Cortical Regions Involved in Neurogenic Bladder in MSNeurogenic overactive bladder (NOAB), characterized by urinary frequency, urgency or urgency incontinence symptoms occurring during the storage phase of the bladder, is the most…NCT06072703·Houston, Texas

TerminatedAugmenting Cerebral Blood Flow to Treat Established Multiple SclerosisThis study will evaluate how improved cerebral blood flow affects the way in which newly formed MS lesions evolve and whether tissue repair is improved.NCT02466074·Houston, Texas

RecruitingCare in Multiple Sclerosis (MS)This study is structured around three main aims.NCT07011914·Birmingham, Alabama and 5 others

CompletedAssessment of ANK-700 in Patients With Relapsing Remitting Multiple SclerosisA safety study of ANK-700 in patients with relapsing remitting multiple sclerosis.NCT04602390·Cullman, Alabama and 14 others

CompletedA Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)This study will evaluate the efficacy and safety of ocrelizumab in participants with RRMS who have had a suboptimal response to an adequate course of DMT.NCT02637856·Cullman, Alabama and 81 others

CompletedBrain Targets in Patients With Bladder Emptying DifficultiesThe goal of this study is to identify brain centers specifically associated with "initiation of voiding" in patients with neurogenic bladder dysfunction.NCT03574610·Houston, Texas

Active not recruitingOcrelizumab Discontinuation in Relapsing Multiple SclerosisThis study is a prospective, multi-center, randomized, double blinded, placebo-controlled study of OCR treatment-discontinuation in patients with early RMS.NCT05285891·New Haven, Connecticut and 12 others

CompletedProspective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With OcrelizumabOpen-label, prospective, single-arm, multi-center study to assess disease activity and biomarker of neuronal damage in minority patients (self-identified Black or African American…NCT04377555·Phoenix, Arizona and 27 others

CompletedA Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple SclerosisThis study seeks to evaluate the safety, tolerability, pharmacokinetics (PK) and immunogenicity of ABT-555 in participants with relapsing forms of multiple sclerosis (RFMS).NCT02601885·Orlando, Florida and 7 others

CompletedSafety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)The objective of the trial is to study the safety and effectiveness of ABT-874 administered weekly or every other week in patients with relapsing remitting and secondary…NCT00086671·Phoenix, Arizona and 43 others

PreviousPage 5 of 6Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia